Discriminating active from latent tuberculosis by Mycobacterium tuberculosis (MTB)-peptide specific immunoresponses

D. Goletti (Roma, Italy)

Source: Annual Congress 2008 - Priorities for tuberculosis research in Europe: discussing the results of the Tuberculosis Network European Trials Group (TBNET)
Disease area: Respiratory infections

Slide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Goletti (Roma, Italy). Discriminating active from latent tuberculosis by Mycobacterium tuberculosis (MTB)-peptide specific immunoresponses. Annual Congress 2008 - Priorities for tuberculosis research in Europe: discussing the results of the Tuberculosis Network European Trials Group (TBNET)

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Evaluation of a IFN-γ test using Mycobacterium tuberculosis-specific antigens for diagnosis of active tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 142s
Year: 2006

Mycobacterium tuberculosis resistance
Source: Eur Respir J 2002; 20: Suppl. 38, 360s
Year: 2002

Latent tuberculosis
Source: Respipedia Article
Year: 2018

Immunological differences between lung tuberculosis and latent tuberculosis infection
Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools
Year: 2018

Comparison of T-cell interferon-γ release assay to mycobacterium tuberculosis-specific antigens in patients with active and latent tuberculosis
Source: Annual Congress 2009 - Tuberculosis contact screening
Year: 2009


Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019


Impact of T-SPOT.TB test to exclude active Mycobacterium tuberculosis complex infection in patients with mycobacterial disease
Source: Eur Respir J 2006; 28: Suppl. 50, 139s
Year: 2006

Drug resistance of Mycobacterium tuberculosis isolated from tuberculosis inflammatory foci
Source: Eur Respir J 2005; 26: Suppl. 49, 654s
Year: 2005

Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection
Source: Eur Respir J 2011; 38: 1237-1238
Year: 2011


Importance of identifying Mycobacterium bovis as a causative agent of human tuberculosis
Source: Eur Respir J 2010; 35: 692-694
Year: 2010


Deficient in silico selection of mycobacterium tuberculosis (MTB) epitopes in tuberculosis (TB) patients
Source: Eur Respir J 2006; 28: Suppl. 50, 801s
Year: 2006

Identification of Mycobacterium tuberculosis (MTB)-infection in immunocompromised hosts
Source: Annual Congress 2008 - Priorities for tuberculosis research in Europe: discussing the results of the Tuberculosis Network European Trials Group (TBNET)
Year: 2008


Detection of Mycobacterium tuberculosis in children during complex antimycobacterial therapy
Source: Annual Congress 2009 - Genetics of lung diseases
Year: 2009

Comparison of two commercial interferon-γ assays for diagnosing Mycobacterium tuberculosis infection
Source: Eur Respir J 2006; 28: 24-30
Year: 2006



Quantitative T-cell interferon-gamma responses to Mycobacterium tuberculosis-specific antigens in latent and active tuberculosis
Source: Annual Congress 2008 - New tools in tuberculosis diagnosis
Year: 2008

Multiple cytokine response to mycobacterium tuberculosis with a whole blood assay is useful to distinguish active from latent tuberculosis infection in a highly tuberculosis endemic country
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014


Risk factors for Mycobacterium tuberculosis infection among contacts of pulmonary tuberculosis patients
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I
Year: 2012


Investigation of the inhibition of adherence of Mycobacterium avium complex (MAC) and Mycobacterium tuberculosis (MTB) to the respiratory mucosa
Source: Eur Respir J 2001; 18: Suppl. 33, 480s
Year: 2001

Interferon-? release assays for the diagnosis of latent Mycobacterium tuberculosis infection
Source: Eur Respir J 2011; 38: 1238-1239
Year: 2011